These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34736575)

  • 1. Use of oral estradiol plus vaginal progesterone in healthy postmenopausal women.
    Sriprasert I; Mert M; Mack WJ; Hodis HN; Shoupe D
    Maturitas; 2021 Dec; 154():13-19. PubMed ID: 34736575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
    N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
    Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules).
    Lobo RA; Liu J; Stanczyk FZ; Constantine GD; Pickar JH; Shadiack AM; Bernick B; Mirkin S
    Menopause; 2019 Jul; 26(7):720-727. PubMed ID: 30694918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G; Spritzer PM
    Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
    Sun A; Lin S; Wei Y
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Serum Estradiol Levels Among Postmenopausal Women Using Hormone Therapy.
    Sriprasert I; Kono N; Karim R; Hodis HN; Stanczyk FZ; Shoupe D; Mack WJ
    Obstet Gynecol; 2020 Oct; 136(4):675-684. PubMed ID: 32925623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR).
    Mirkin S; Goldstein SR; Archer DF; Pickar JH; Graham S; Bernick B
    Menopause; 2020 Apr; 27(4):410-417. PubMed ID: 31913228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of menopausal hormone therapy on arterial wall echomorphology: Results from the Early versus Late Intervention Trial with Estradiol (ELITE).
    Karim R; Xu W; Kono N; Sriprasert I; Li Y; Yan M; Stanczyk FZ; Shoupe D; Mack WJ; Hodis HN
    Maturitas; 2022 Aug; 162():15-22. PubMed ID: 35474254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial safety of ultra-low-dose estradiol vaginal tablets.
    Simon J; Nachtigall L; Ulrich LG; Eugster-Hausmann M; Gut R
    Obstet Gynecol; 2010 Oct; 116(4):876-883. PubMed ID: 20859151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
    Lobo RA; Archer DF; Kagan R; Kaunitz AM; Constantine GD; Pickar JH; Graham S; Bernick B; Mirkin S
    Obstet Gynecol; 2018 Jul; 132(1):161-170. PubMed ID: 29889748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
    Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
    Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women.
    Ross D; Cooper AJ; Pryse-Davies J; Bergeron C; Collins WP; Whitehead MI
    Am J Obstet Gynecol; 1997 Oct; 177(4):937-41. PubMed ID: 9369848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High local endometrial effect of vaginal progesterone gel.
    Ficicioglu C; Gurbuz B; Tasdemir S; Yalti S; Canova H
    Gynecol Endocrinol; 2004 May; 18(5):240-3. PubMed ID: 15346659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
    Genazzani AR; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.